Doesn't fuss me actually
I am only focussed on the bottom line NPAT come report time, and EPS.
I have previously stated I hold the opinion that with roll-ups EBITDA might be a key acquisition metric, but for market valuation purposes we need to see efficient fall of earnings to NPAT and EPS.
Cheers
Gosouth
- Forums
- ASX - By Stock
- HLA
- Ann: HEALTHIA ANNOUNCES NEW QLD AND VIC GROWTH ACQUISITIONS
Ann: HEALTHIA ANNOUNCES NEW QLD AND VIC GROWTH ACQUISITIONS, page-19
Featured News
Add HLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO & MD
Anthony Noble
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online